Quan-Yong LUO; Li-Bo CHEN; Yong-Li YU; Han-Kui LU; Rui-Sen ZHU

您当前的位置：

首页 >

文章列表页 >

Changes in percentage of lymphocyte subsets after ¹³¹I treatment in patients with differentiated thyroid cancer

RADIOCHEMISTRY, RADIOPHARMACEUTICALS AND NUCLEAR MEDICINE | 更新时间：2021-01-29

- Changes in percentage of lymphocyte subsets after ¹³¹I treatment in patients with differentiated thyroid cancer 封面论文增强出版
- Changes in percentage of lymphocyte subsets after ¹³¹I treatment in patients with differentiated thyroid cancer
- 核技术（英文版） 2005年 16卷第4期 (2005)
- 作者机构：
  
  Department of Nuclear Medicine, Shanghai Sixth People's Hospital, Shanghai Jiaotong University,Shanghai,200233
- 作者简介：
- 基金信息：
  
  Science and Technology Development Fund of Shanghai
- DOI：中图分类号： R736.1,R817.5
- 纸质出版日期：2005-08-01，
  
  网络出版日期：，
  
  收稿日期：2005-01-21，
  
  修回日期：，
  
  录用日期：
扫描看全文
引用本文
Quan-Yong LUO, Li-Bo CHEN, Yong-Li YU, 等. Changes in percentage of lymphocyte subsets after ¹³¹I treatment in patients with differentiated thyroid cancer[J]. 核技术（英文版）, 2005, 16(4):214-216.

Quan-Yong LUO, Li-Bo CHEN, Yong-Li YU, et al. Changes in percentage of lymphocyte subsets after ¹³¹I treatment in patients with differentiated thyroid cancer[J]. Nuclear Science and Techniques, 2005, 16(4):214-216.
Quan-Yong LUO, Li-Bo CHEN, Yong-Li YU, 等. Changes in percentage of lymphocyte subsets after ¹³¹I treatment in patients with differentiated thyroid cancer[J]. 核技术（英文版）, 2005, 16(4):214-216. DOI：

Quan-Yong LUO, Li-Bo CHEN, Yong-Li YU, et al. Changes in percentage of lymphocyte subsets after ¹³¹I treatment in patients with differentiated thyroid cancer[J]. Nuclear Science and Techniques, 2005, 16(4):214-216. DOI：

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

Investigation of combined degrader for Proton facility based on BDSIM/FLUKA Monte Carlo methods

Efficient adsorption of Th(IV) from aqueous solution by modified SBA-15 mesoporous silica

A preliminary clinic dosimetry study for synchrotron radiation therapy at SSRF

Biological distribution of ¹³¹I-labeled anti-nucleus antigen monoclonal antibody chTNT in patients with pulmonary metastases from differentiated thyroid carcinoma

Influencing factors of radioiodine therapy in hyperthyroidism in adults

Changes in percentage of lymphocyte subsets after 131I treatment in patients with differentiated thyroid cancer 封面论文 增强出版

Changes in percentage of lymphocyte subsets after ¹³¹I treatment in patients with differentiated thyroid cancer 封面论文增强出版